Effects of the combination of low-level laser irradiation and recombinant human bone morphogenetic protein-2 in bone repair


Autoria(s): Rosa, Anderson Paim; Sousa, Luiz Gustavo de; Regalo, Simone Cecilio Hallak; Issa, João Paulo Mardegan; Barbosa, Ana Paula Amorim; Pitol, Dimitrius Leonardo; Oliveira, Richard Honorato de; Vasconcelos, Paulo Batista de; Dias, Fernando José; Sousa, Daniela Thomazatti Chimello de; Siessere, Selma
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

06/11/2013

06/11/2013

2012

Resumo

Low-level laser irradiation (LLLI) and recombinant human bone morphogenetic protein type 2 (rhBMP-2) have been used to stimulate bone formation. LLLI stimulates proliferation of osteoblast precursor cells and cell differentiation and rhBMP-2 recruits osteoprogenitor cells to the bone healing area. This in vivo study evaluated the effects of LLLI and rhBMP-2 on the bone healing process in rats. Critical bone defects were created in the parietal bone in 42 animals, and the animals were divided into six treatment groups: (1) laser, (2) 7 mu g of rhBMP-2, (3) laser and 7 mu g of rhBMP-2, (4) 7 mu g of rhBMP-2/monoolein gel, (5) laser and 7 mu g rhBMP-2/monoolein gel, and (6) critical bone defect controls. A gallium-aluminum-arsenide diode laser was used (wavelength 780 nm, output power 60 mW, beam area 0.04 cm(2), irradiation time 80 s, energy density 120 J/cm(2), irradiance 1.5 W/cm(2)). After 15 days, the calvarial tissues were removed for histomorphometric analysis. Group 3 defects showed higher amounts of newly formed bone (37.89%) than the defects of all the other groups (P < 0.05). The amounts of new bone in defects of groups 1 and 4 were not significantly different from each other (24.00% and 24.75%, respectively), but were significantly different from the amounts in the other groups (P < 0.05). The amounts of new bone in the defects of groups 2 and 5 were not significantly different from each other (31.42% and 31.96%, respectively), but were significantly different from the amounts in the other groups (P < 0.05). Group 6 defects had 14.10% new bone formation, and this was significantly different from the amounts in the other groups (P < 0.05). It can be concluded that LLLI administered during surgery effectively accelerated healing of critical bone defects filled with pure rhBMP-2, achieving a better result than LLLI alone or the use of rhBMP-2 alone.

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/51480-4]

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)

Pro-Reitoria de Pesquisa da Universidade de Sao Paulo

Identificador

LASERS IN MEDICAL SCIENCE, LONDON, v. 27, n. 5, pp. 971-977, SEP, 2012

0268-8921

http://www.producao.usp.br/handle/BDPI/42626

10.1007/s10103-011-1022-y

http://dx.doi.org/10.1007/s10103-011-1022-y

Idioma(s)

eng

Publicador

SPRINGER LONDON LTD

LONDON

Relação

LASERS IN MEDICAL SCIENCE

Direitos

closedAccess

Copyright SPRINGER LONDON LTD

Palavras-Chave #LOW-LEVEL LASER IRRADIATION #BONE REPAIR #BONE MORPHOGENETIC PROTEINS #ANIMALS #IN-VITRO #DEFECTS #THERAPY #RHBMP-2 #LIGHT #CELLS #RATS #ENGINEERING, BIOMEDICAL #SURGERY
Tipo

article

original article

publishedVersion